Sonova Holding
Financials
Estimates*
EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 2.2b | 2.8b | 3.1b | 3.0b | 3.2b | 3.5b | 3.7b |
% growth | (11 %) | 29 % | 11 % | (3 %) | 7 % | 7 % | 7 % |
EBITDA | 702m | 809m | 822m | 763m | 839m | 918m | 1.0b |
% EBITDA margin | 32 % | 29 % | 26 % | 25 % | 26 % | 26 % | 27 % |
Profit | 484m | 541m | 540m | 501m | 508m | 574m | 628m |
% profit margin | 22 % | 19 % | 17 % | 17 % | 16 % | 17 % | 17 % |
EV / revenue | 6.1x | 7.5x | 4.7x | 4.7x | 4.9x | 4.5x | 4.2x |
EV / EBITDA | 18.8x | 25.9x | 17.9x | 18.5x | 18.8x | 17.1x | 15.4x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | $34.5k | Growth Equity non VC |
Total Funding | - |
Recent News about Sonova Holding
EditSonova is a global leader in innovative hearing solutions, serving individuals with hearing loss through advanced technology and personalized care. Operating in the healthcare sector, Sonova provides a wide range of hearing instruments and cochlear implants under various brands such as Phonak, Unitron, and Advanced Bionics. The company caters to a diverse clientele, including individuals with mild to profound hearing loss, across multiple markets worldwide. Sonova's business model revolves around the development, manufacturing, and distribution of hearing aids and related services. Revenue is generated through the sale of these products and services, as well as through partnerships with healthcare providers and retail chains. The company also emphasizes corporate responsibility, focusing on sustainable practices and community engagement through initiatives like the Hear the World Foundation.
Keywords: hearing solutions, hearing aids, cochlear implants, Phonak, Unitron, Advanced Bionics, healthcare, personalized care, innovation, sustainability.